Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Molassiotis, AlexanderFernandez-Ortega, Paz
Pud, Dorit
Ozden, Gulten
Platin, Nurgun
Hummerston, Sandra
Scott, Julia A
Panteli, Vassiliki
Gudmundsdottir, Gudbjorg
Selvekerova, Sarka
Patiraki, Elisabeth
Kearney, Nora
Issue Date
2005-12-01
Metadata
Show full item recordCitation
Complement Ther Med 2005, 13(4):251-7Abstract
PURPOSE: The aim of the present study was to examine the use of complementary and alternative medicine (CAM) in a sample of colorectal cancer patients in Europe. METHODS: The study was a descriptive cross-sectional survey and data were collected through a 27-item self-reported questionnaire from seven European countries. RESULTS: As part of a larger study, 126 colorectal cancer patients participated in this survey. Among the participants, 32% used CAM after the diagnosis of cancer. Almost half the CAM therapies used were new therapies, never tried before the diagnosis. The most common CAM therapies used included herbal medicine (48.7%), homeopathy (20.5%), use of vitamins/minerals (17.9%), spiritual therapies (15.4%), medicinal teas (15.4%) and relaxation techniques (12.8%). A dramatic increase was observed in the use of CAM from usage levels before the cancer diagnosis. High levels of satisfaction with CAM were also reported. Patients used CAM more often to increase the body's ability to fight the cancer or to improve physical well-being. However, expectations did not always match with the benefits reported. CONCLUSIONS: As one-third of colorectal cancer patients use CAM, health professionals should be more aware of this approach to the patient's management. They should discuss the role of CAM therapies with their patients in a non-judgemental and open manner, and endeavour to provide accurate information in order to allow patients to make their own decision about CAM.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional LinkAdditional Links
http://www.sciencedirect.com/science/article/B6WCS-4H4T31C-1/2/10eb943d44fd9ac5a72248683ba8666fae974a485f413a2113503eed53cd6c53
10.1016/j.ctim.2005.07.002
Scopus Count
Collections
Related articles
- Complementary and alternative medicine use in lung cancer patients in eight European countries.
- Authors: Molassiotis A, Panteli V, Patiraki E, Ozden G, Platin N, Madsen E, Browall M, Fernandez-Ortega P, Pud D, Margulies A
- Issue date: 2006 Feb
- Complementary and alternative medicine use in patients with haematological malignancies in Europe.
- Authors: Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, Scott JA, Gudmundsdottir G, Browall M, Madsen E, Ozden G, Magri M, Selvekerova S, Platin N, Kearney N, Patiraki E
- Issue date: 2005 May
- Use of complementary and alternative medicine among cancer patients in Israel.
- Authors: Pud D, Kaner E, Morag A, Ben-Ami S, Yaffe A
- Issue date: 2005 Jun
- Complementary and alternative medicine use in patients with head and neck cancers in Europe.
- Authors: Molassiotis A, Ozden G, Platin N, Scott JA, Pud D, Fernandez-Ortega P, Milovics L, Panteli V, Gudmundsdottir G, Browall M, Madsen E, Patiraki E, Kearney N
- Issue date: 2006 Mar
- Frequency of use of complementary and alternative medicine in women with breast cancer.
- Authors: Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE
- Issue date: 2002 Nov-Dec